News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
435,309 Results
Type
Article (23947)
Company Profile (151)
Press Release (411211)
Section
Business (132383)
Career Advice (1073)
Deals (25627)
Drug Delivery (99)
Drug Development (63596)
Employer Resources (92)
FDA (10610)
Job Trends (9648)
News (236074)
Policy (22199)
Tag
Academia (1141)
Alliances (33471)
Alzheimer's disease (907)
Approvals (10589)
Artificial intelligence (125)
Bankruptcy (239)
Best Places to Work (7325)
Breast cancer (128)
Cancer (1165)
Cardiovascular disease (98)
Career advice (884)
CAR-T (90)
Cell therapy (224)
Clinical research (52245)
Collaboration (412)
Compensation (144)
COVID-19 (1428)
C-suite (101)
Data (1174)
Diabetes (149)
Diagnostics (3328)
Drug pricing (102)
Earnings (53619)
Employer resources (83)
Events (63525)
Executive appointments (346)
FDA (11186)
Funding (321)
Gene therapy (166)
GLP-1 (562)
Government (2516)
Healthcare (9826)
Infectious disease (1502)
Inflammatory bowel disease (92)
Interviews (149)
IPO (11618)
Job creations (2662)
Job search strategy (793)
Layoffs (275)
Legal (4936)
Lung cancer (172)
Lymphoma (91)
Manufacturing (178)
Medical device (5824)
Medtech (5828)
Mergers & acquisitions (14244)
Metabolic disorders (455)
Neuroscience (1185)
NextGen: Class of 2025 (3294)
Non-profit (1461)
Northern California (1275)
Obesity (275)
Opinion (197)
Patents (119)
People (38275)
Pharmaceutical (81)
Phase I (16466)
Phase II (22807)
Phase III (17345)
Pipeline (539)
Postmarket research (1805)
Preclinical (6215)
Radiopharmaceuticals (192)
Rare diseases (227)
Real estate (3641)
Regulatory (15886)
Research institute (1149)
Resumes & cover letters (164)
Southern California (1158)
Startups (2299)
United States (11452)
Vaccines (294)
Weight loss (221)
Date
Last 7 days (492)
Last 30 days (1395)
Last 365 days (25533)
2025 (1146)
2024 (25842)
2023 (28768)
2022 (36259)
2021 (37760)
2020 (35567)
2019 (27248)
2018 (20733)
2017 (22368)
2016 (20553)
2015 (24316)
2014 (18539)
2013 (15315)
2012 (16253)
2011 (16838)
2010 (15559)
Location
Africa (495)
Arizona (82)
Asia (31246)
Australia (5888)
California (2892)
Canada (1177)
China (296)
Colorado (137)
Connecticut (153)
Europe (61932)
Florida (441)
Illinois (257)
Indiana (173)
Japan (88)
Maryland (417)
Massachusetts (2347)
Minnesota (154)
New Jersey (959)
New York (860)
North Carolina (556)
Northern California (1275)
Ohio (92)
Pennsylvania (714)
South America (741)
Southern California (1158)
Texas (419)
Washington State (341)
435,309 Results for "natco pharma limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Natco Pharma Limited Completes Transition of DASH Pharmaceuticals into Natco Pharma USA, Furthering Strategic Presence in the United States
Natco Pharma Limited, a research and development -focused pharmaceutical company based in India, announced that DASH Pharmaceuticals, a company that markets, sells, and distributes generic pharmaceutical products, has officially transitioned to Natco Pharma USA, the U.S. subsidiary of Natco Pharma.
January 2, 2024
·
3 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
January 16, 2025
·
5 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
January 14, 2025
·
5 min read
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
Piramal Pharma Limited Announces Results for Q4 and FY2024
Piramal Pharma Limited, a leading global pharmaceuticals company, announced its standalone and consolidated results for the Fourth Quarter and Full Year ended 31st March 2024.
May 10, 2024
·
8 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Business
The Biggest Pharma Share Moves of the Year So Far
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.
November 27, 2024
·
9 min read
·
Annalee Armstrong
Business
Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
Teva Pharmaceuticals and NATCO Pharma Limited (NSE: NATCOPHARM; BSE: 524816), announced today the launch of additional strengths for the generic version of Revlimid® 1 (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States.
March 9, 2023
·
15 min read
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Deals
Two Private Equity Firms Near Potential $3B+ Deal for Mitsubishi’s Pharma Unit: Reuters
Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.
December 13, 2024
·
1 min read
·
Annalee Armstrong
1 of 43,531
Next
